(Q53060269)

English

Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.

scientific article published in September 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

0 references

0 references

1 reference

based on heuristic

inferred from title

hypoestrogenism

1 reference

based on heuristic

inferred from title

Naibedya Chattopadhyay

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Abdul Malik Tyagi

object named as

Abdul M Tyagi

1

0 references

author name string

Mohd N Mansoori

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Kamini Srivastava

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Mohd P Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Jyoti Kureel

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Manisha Dixit

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Priyanka Shukla

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Ritu Trivedi

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Divya Singh

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

29

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

1981-1992

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

The role of the immune system in the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Functions and mechanisms of green tea catechins in regulating bone remodeling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Bone remodeling in post-menopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Osteoporosis treatment and prevention for postmenopausal women: current and future therapeutic options

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Osteoporosis, inflammation and ageing

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

T cells and post menopausal osteoporosis in murine models

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Safety concerns with the long-term management of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Effects of anti-tumor necrosis factor α agents on bone

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Immunogenicity and autoimmunity during anti-TNF therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Anti-TNF therapy: safety aspects of taking the risk

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Infliximab reduces the frequency of interleukin 17-producing cells and the amounts of interleukin 17 in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Interleukin-17 and type 17 helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

RANKL-RANK signaling in osteoclastogenesis and bone disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

TNF-α mediates the stimulation of sclerostin expression in an estrogen-deficient condition

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

In vitro morpho-functional analysis of pancreatic islets isolated from the domestic chicken

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

B cells and osteoblast and osteoclast development

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

FOXP3 and the regulation of Treg/Th17 differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

TH17 cells in development: an updated view of their molecular identity and genetic programming

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

T lymphocyte surface antigen markers in osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Ovariectomy-induced bone loss occurs independently of B cells.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T cells in mice

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2228

21 January 2018

Identifiers

10.1002/JBMR.2228

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24677326

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53060269&oldid=1587403101"